OR Royalties (NYSE:OR) Issues Quarterly Earnings Results

OR Royalties (NYSE:OR) posted its earnings results on Wednesday. The basic materials company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.31 by $0.01, Zacks reports. OR Royalties had a net margin of 60.72% and a return on equity of 10.67%. The firm had revenue of $90.47 million for the quarter, compared to analysts’ expectations of $90.80 million.

OR Royalties Price Performance

NYSE:OR traded down $0.74 on Thursday, reaching $42.79. 95,424 shares of the company’s stock were exchanged, compared to its average volume of 1,545,421. The firm has a market cap of $8.02 billion, a price-to-earnings ratio of 53.91 and a beta of 0.76. The stock has a fifty day simple moving average of $39.74 and a 200-day simple moving average of $36.07. OR Royalties has a 52 week low of $17.55 and a 52 week high of $47.75.

OR Royalties Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 15th. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.055 per share. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $0.22 annualized dividend and a yield of 0.5%. OR Royalties’s dividend payout ratio is 27.85%.

Trending Headlines about OR Royalties

Here are the key news stories impacting OR Royalties this week:

• Positive Sentiment: OR reported record 2025 results — annual revenue of $277.4M and record operating cash flow of $245.6M — and provided 2026 GEO delivery guidance plus a new 5‑year outlook, giving investors stronger visibility on growth and cash generation. OR Royalties Reports Record 2025 Results and Provides 2026 GEO Delivery Guidance and New 5-Year Outlook
• Positive Sentiment: OR agreed to buy a portfolio of eight royalties for $115M, anchored by a 1.5% NSR on Buenaventura’s producing San Gabriel gold/silver mine — an asset that should add near-term royalty cash flow and diversify the portfolio. OR Royalties Announces Acquisition of a Portfolio of Royalty Assets MSN coverage
• Positive Sentiment: The board declared a Q1 2026 dividend of US$0.055 per share and outlined DRIP requirements — supporting the stock’s income appeal and signaling management’s confidence in cash flow. OR Royalties Declares First Quarter 2026 Dividend TipRanks announcement
• Positive Sentiment: Q4 results: EPS of $0.32 beat consensus by $0.01 and margins/ROE remain healthy (net margin ~60.7%, ROE ~10.7%), reinforcing profitability despite revenue essentially in line with estimates. Press Release
• Neutral Sentiment: Analyst/commentary pieces compared OR to larger miners (e.g., BHP) to contextualize valuation and exposure to royalties vs. operating miners; useful for relative valuation but not company-specific catalysts. Comparing BHP Group and OR Royalties
• Negative Sentiment: Revenue for the quarter was essentially flat vs. estimates (reported $90.47M vs. $90.80M est.), a small miss that highlights sensitivity of royalty revenue to mine throughput/metal prices; also note the stock’s elevated P/E, which could amplify downside if guidance or commodity prices disappoint. Press Release

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. FIL Ltd purchased a new stake in shares of OR Royalties during the fourth quarter worth $29,000. Wells Fargo & Company MN lifted its holdings in OR Royalties by 6.2% during the 4th quarter. Wells Fargo & Company MN now owns 5,901 shares of the basic materials company’s stock worth $209,000 after purchasing an additional 346 shares in the last quarter. Merit Financial Group LLC bought a new position in OR Royalties in the 3rd quarter worth about $215,000. Flow Traders U.S. LLC purchased a new position in OR Royalties during the 3rd quarter valued at about $217,000. Finally, Moors & Cabot Inc. purchased a new position in OR Royalties during the 3rd quarter valued at about $220,000. 68.52% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Canaccord Genuity Group raised OR Royalties from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, October 22nd. Raymond James Financial raised OR Royalties from a “market perform” rating to an “outperform” rating and set a $41.00 target price for the company in a research report on Thursday, November 6th. Wall Street Zen upgraded OR Royalties from a “buy” rating to a “strong-buy” rating in a research note on Monday, January 19th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of OR Royalties in a research report on Wednesday, February 4th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of OR Royalties in a research report on Monday, December 29th. Two equities research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $38.25.

About OR Royalties

OR Royalties PLC (NYSE: OR) is a closed-ended investment company that specializes in acquiring and managing royalty interests in life science and pharmaceutical products. The company provides capital to biotechnology, specialty pharmaceutical and medical device companies in exchange for a share of future sales revenues. By focusing on royalties secured against marketed products, OR Royalties aims to deliver income and growth potential while minimizing the development and commercialization risks typically associated with direct equity stakes.

The company’s core activities include sourcing royalty transactions, structuring bespoke financing solutions and actively monitoring a diversified portfolio of assets.